Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Cell
.
2019 Jan 10;176(1-2):404.
doi: 10.1016/j.cell.2018.12.034.
Authors
Moshe Sade-Feldman
,
Keren Yizhak
,
Stacey L Bjorgaard
,
John P Ray
,
Carl G de Boer
,
Russell W Jenkins
,
David J Lieb
,
Jonathan H Chen
,
Dennie T Frederick
,
Michal Barzily-Rokni
,
Samuel S Freeman
,
Alexandre Reuben
,
Paul J Hoover
,
Alexandra-Chloé Villani
,
Elena Ivanova
,
Andrew Portell
,
Patrick H Lizotte
,
Amir R Aref
,
Jean-Pierre Eliane
,
Marc R Hammond
,
Hans Vitzthum
,
Shauna M Blackmon
,
Bo Li
,
Vancheswaran Gopalakrishnan
,
Sangeetha M Reddy
,
Zachary A Cooper
,
Cloud P Paweletz
,
David A Barbie
,
Anat Stemmer-Rachamimov
,
Keith T Flaherty
,
Jennifer A Wargo
,
Genevieve M Boland
,
Ryan J Sullivan
,
Gad Getz
,
Nir Hacohen
PMID:
30633907
PMCID:
PMC6647017
DOI:
10.1016/j.cell.2018.12.034
No abstract available
Publication types
Published Erratum
Grants and funding
R01 CA208756/CA/NCI NIH HHS/United States
T32 CA207021/CA/NCI NIH HHS/United States
T32 HG002295/HG/NHGRI NIH HHS/United States
U54 CA224068/CA/NCI NIH HHS/United States